BIOSIMILAR AVT03
Alvotech, Dr. Reddy's ink pact for commercialisation of denosumabAlvotech and Dr. Reddy's partner for AVT03, a biosimilar to Prolia and Xgeva, treating osteoporosis and skeletal-related events. The agreem...21 May, 2024, 09.24 PM IST
Load More